ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279 on “Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents”. Our team contributes to the CRC with a project on hyperpolarized nanodiamond as contrast agents for cancer research. Funded initially for a period of 4 years the CRC may be extended for a duration of up to 12 years.
ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279
News
Julen Pedernales did it again, Best Post Prize at the UniKORN Poster Session 2021
Martin Plenio is listed as highly cited researcher for the fourth time in a row.
Our work on Quantum Physics and Biology featured Local and National Radio
Ludovico Lami wins a Humboldt Fellowship to continue his work in our group for another 2 years
Most Recent Papers
Convergence rates for the quantum central limit theorem, Commun. Math. Phys. 383 (2021) 223–279
Energy-constrained discrimination of unitaries, quantum speed limits and a Gaussian Solovay-Kitaev theorem, Phys. Rev. Lett. 126, 190504
Coherence of operations and interferometry, Phys. Rev. A 103, 042426
Contact
Ulm University
Institute of Theoretical Physics
Albert-Einstein-Allee 11
D - 89069 Ulm
Germany
Tel: ++49 / 731 / 50 - 22911
Fax: ++49 / 731 / 50 - 22924
Office: Building M26, room 4117
Click here if you are interested in applying to the group